BRD4 and ovarian carcinoma: Importantly, a recent study demonstrated that the activity of BRD4 was necessary for proliferation and survival of two ovarian cell line, and the results of BRD4 inhibition in vitro or in vivo suggested that BRD4 was a potential therapeutic target for ovarian cancer (Baratta et al. 2015).